Relevant bibliographies by topics / Dyslipidaemic

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Dyslipidaemic'

Author: Grafiati
Published: 5 June 2025
Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Dyslipidaemic.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Dyslipidaemic"

1

Batista, Kamila Sabino, Adriano Francisco Alves, Marcos dos Santos Lima, et al. "Beneficial effects of consumption of acerola, cashew or guava processing by-products on intestinal health and lipid metabolism in dyslipidaemic female Wistar rats." British Journal of Nutrition 119, no. 1 (2018): 30–41. http://dx.doi.org/10.1017/s0007114517003282.

Full text
Abstract:
AbstractThis study assessed the effects of diet supplementation with industrial processing by-products of acerola (Malpighia emarginataD.C.), cashew (Anacardium occidentaleL.) and guava (Psidium guajavaL.) fruit on the intestinal health and lipid metabolism of female Wistar rats with diet-induced dyslipidaemia. Female rats were randomly divided into five groups: healthy control, dyslipidaemic control and dyslipidaemic experimental receiving acerola, cashew or guava processing by-products. Fruit processing by-products were administered (400 mg/kg body weight) via orogastric administration for 2
APA, Harvard, Vancouver, ISO, and other styles
2

Tasnim, Tasmia, Kazi Muhammad Rezaul Karim, and Chaity Bhatta. "Association of diet quality and nutrient intake with odds of dyslipidaemia in patients with cardiovascular diseases: a hospital based cross-sectional study in Bangladesh." BMJ Open 14, no. 12 (2024): e091025. https://doi.org/10.1136/bmjopen-2024-091025.

Full text
Abstract:
ObjectiveThe aim of this study is to evaluate diet quality and other associated factors with dyslipidaemia in cardiovascular disease (CVD) patients in Bangladesh.DesignThe study employed a cross-sectional design.SettingData from medical records, dietary intake and socioeconomic factors were collected from January to October 2022 at the National Institute of Cardiovascular Disease, Dhaka, and Noakhali Sadar Hospital.ParticipantsA total of 570 CVD patients, aged 25–80 years, with a confirmed diagnosis within the past 3 months, were included in the study.Main outcome measuresThe primary outcomes
APA, Harvard, Vancouver, ISO, and other styles
3

Jain, Shilpa, and J. L. Marko. "Cost variation analysis of oral anti-dyslipidaemic drugs available in Indian pharmaceutical market." International Journal of Basic & Clinical Pharmacology 9, no. 5 (2020): 753. http://dx.doi.org/10.18203/2319-2003.ijbcp20201752.

Full text
Abstract:
Background: Dyslipidaemia is one of major risk factor contributing to cardiovascular disease, which further causes mortality and morbidity, so requires a long course of treatment. Physicians should be aware of the cost of drugs.Methods: Cost of the oral anti-dyslipidaemic drug, either as single drug or in combination manufactured by different pharmaceutical companies in the same strength and dosage form was obtained from current index of medical specialities (CIMS) April-July 2019. The difference in the maximum and minimum price of the same drug manufactured by different pharmaceutical compani
APA, Harvard, Vancouver, ISO, and other styles
4

de Araújo, Emmanuel Veríssimo, Keyth Sulamitta de Lima Guimarães, Marciane Magnani, et al. "Maternal dyslipidemia during pregnancy and lactation increases blood pressure and disrupts cardiorespiratory and glucose hemostasis in female rat offspring." Applied Physiology, Nutrition, and Metabolism 44, no. 9 (2019): 925–36. http://dx.doi.org/10.1139/apnm-2018-0756.

Full text
Abstract:
Hypertension and metabolic disorders evidenced in adults who have been exposed to nutritional insults during early life may be sex-dependent. We evaluated if blood pressure (BP), cardiorespiratory control, and metabolic parameters are affected in female offspring (FO) from dams fed a dyslipidaemic diet during pregnancy and lactation. FO was obtained from dams who received control (CTL) or dyslipidaemic diets during pregnancy and lactation. The effects of a maternal dyslipidaemic diet on BP, cardiorespiratory control, and biochemical parameters were assessed at 30 and 90 days of age. The experi
APA, Harvard, Vancouver, ISO, and other styles
5

HALDER, SUJASH, RAHUL DAS, and SWAGATA KOLEY. "<b>Estimation of lipid profile among prediabetic and diabetic patients attending Central laboratory, in an apex medical college in eastern India: An observational study</b>." National Journal of Physiology, Pharmacy and Pharmacology 14, no. 12 (2024): 2530. https://doi.org/10.5455/njppp.2024.v14.i12.6.

Full text
Abstract:
&lt;b&gt;Background:&lt;/b&gt; Dyslipidaemia is a metabolic disorder of lipoproteins characterized by abnormal lipid profile. India has a huge burden of diabetes mellitus making India the second highest diabetic capital in the world. Dyslipidemia plays a crucial role in different complications in both prediabetes and diabetes patients. &lt;b&gt;Aim:&lt;/b&gt; This study was conducted to assess the lipid profile among both the diabetic patients and prediabetic individuals, in a tertiary care hospital in Eastern India. &lt;b&gt;Methods:&lt;/b&gt; This observational cross-sectional study was cond
APA, Harvard, Vancouver, ISO, and other styles
6

Ceska, Richard. "Clinical implications of the metabolic syndrome." Diabetes and Vascular Disease Research 4, no. 3_suppl (2007): S2—S4. http://dx.doi.org/10.3132/dvdr.2007.049.

Full text
Abstract:
The prevalence of the metabolic syndrome among developed countries is rising, and this is largely driven by increasing obesity rates. Central obesity plays a key role in the pathogenesis of the metabolic syndrome: it promotes inflammation, hypertension and dyslipidaemia, and leads to the development of type 2 diabetes mellitus and atherosclerosis. Clinical management should be focused on multifactorial intervention to address all the associated cardiovascular risk factors. The atherogenic mixed dyslipidaemic profile associated with the metabolic syndrome is an important target for intervention
APA, Harvard, Vancouver, ISO, and other styles
7

Harangi, Mariann, Noémi Zsíros, and Nóra Tóth. "A lipidanyagcsere zavarai endokrin betegségekben." Lege Artis Medicinae 33, no. 10-11 (2023): 511–21. http://dx.doi.org/10.33616/lam.33.0511.

Full text
Abstract:
A dyslipidaemia kulcsszerepet játszik számos cardiovascularis megbetegedés patomechanizmusában. Számos betegnél nem a lipoprotein-anyagcsere primer zavaráról van szó, hanem a dyslipidaemiát valamely „nem lipid” ok magyarázza. Ezen szekunder dyslipidaemiák meglepően gyakoriak, a hátterükben álló eltérések gyakran nem kerülnek felismerésre, hacsak nem keressük őket aktívan. Az endokrin megbetegedések gyakran társulnak dyslipidaemiával, ide sorolható a hypothyreosis, a diabetes mellitus, a Cushing-szindróma, az acromegalia, a hypogonadismus, a növekedésihormon-deficientia, a hyperprolactinaemia é
APA, Harvard, Vancouver, ISO, and other styles
8

Meka, Ijeoma A., Obumneme B. Anyim, Joseph T. Enebe, Kingsley N. Ukwaja, and Martin C. Ugonabo. "Association of miRNA122 & ADAM17 with lipids among hypertensives in Nigeria." Open Medicine 13, no. 1 (2018): 350–58. http://dx.doi.org/10.1515/med-2018-0053.

Full text
Abstract:
AbstractBackgroundDyslipidaemia and hypertension are established major risk factors for cardiovascular diseases. The suggested roles of miRNA-122 and ADAM17 in lipid metabolism can therefore be applied in the management of metabolic disorders. The authors’ aim was to determine the association between miRNA-122 and ADAM17, as well as the association between miRNA-122 and lipid fractions, in the study participants.MethodA comparative cross-sectional study was conducted among 200 hypertensive patients and 100 non-hypertensive adult controls between May, 2015, and June, 2016, in Nigeria. Lipids we
APA, Harvard, Vancouver, ISO, and other styles
9

Chapman, M. John. "Metabolic syndrome and type 2 diabetes: lipid and physiological consequences." Diabetes and Vascular Disease Research 4, no. 3_suppl (2007): S5—S8. http://dx.doi.org/10.3132/dvdr.2007.050.

Full text
Abstract:
The metabolic syndrome and type 2 diabetes are insulin-resistant states which are commonly associated with an atherogenic dyslipidaemia involving mild to moderately elevated triglycerides, a preponderance of small, dense low-density lipoprotein (LDL) particles and low levels of high-density lipoprotein cholesterol (HDL-C). In addition, there is a spectrum of qualitative changes in the lipoprotein profile, particularly in the functional capacity of HDL to facilitate cellular cholesterol efflux and to protect LDL against oxidative modification. Together, these quantitative and qualitative anomal
APA, Harvard, Vancouver, ISO, and other styles
10

Silva, J. M., I. Souza, R. Silva, F. Teixeira, and P. S. Silva. "Fish oils in Portuguese dyslipidaemic patients." Atherosclerosis 115 (June 1995): S45. http://dx.doi.org/10.1016/0021-9150(95)96419-s.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Dyslipidaemic"

1

Toms, Tracey. "Dyslipidaemia in rheumatoid arthritis." Thesis, University of Manchester, 2012. https://www.research.manchester.ac.uk/portal/en/theses/dyslipidaemia-in-rheumatoid-arthritis(e7808bd7-52e6-40a0-84cb-e4aadbf7505c).html.

Full text
Abstract:
Introduction: Rheumatoid arthritis (RA) is known to be associated with an increased risk of cardiovascular disease (CVD), resulting in excess mortality. Dyslipidaemia has been identified as a major CVD risk factor in the general population. Current evidence would suggest that lipid metabolism is altered in RA due to inflammation, and that use of anti-inflammatory therapy may reverse some of these changes. However, the impact of such lipid changes on CVD in RA remains unknown. Data regarding the effects of RA/drug therapy on lipid structure and function are sparse. Genetic factors are important
APA, Harvard, Vancouver, ISO, and other styles
2

Jackson, William. "The effects of atherogenic dyslipidaemia on blood monocyte function." Thesis, Imperial College London, 2015. http://hdl.handle.net/10044/1/38388.

Full text
Abstract:
Blood monocytes are heterogeneous effector cells of the innate immune system that can be divided into at least two functionally distinct subpopulations. In circulation these cells are constantly in contact with lipid-rich lipoproteins, yet this interaction is poorly characterized. The aim of this PhD was to examine the functional response of blood monocyte subpopulations to dyslipidaemia, defined as high levels of plasma VLDL and LDL. Initially in the Ldlr-/- mouse, I demonstrated that monocytes accumulate cytoplasmic neutral lipid vesicles when exposed to high fat diet induced dyslipidaemia.
APA, Harvard, Vancouver, ISO, and other styles
3

Baynes, Christospher. "Insulin action and dyslipidaemia in non-insulin-dependent diabetes." Thesis, University of Southampton, 1992. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.316405.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Field, Polly Ann. "The effects of insulin resistance on chylomicron metabolism." Thesis, University of Oxford, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.302120.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Tan, Chee-Eng. "The relationship between insulin resistance and the atherogenic lipoprotein phenotype." Thesis, University of Glasgow, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.318118.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ellins, Elizabeth Anne. "Clinical investigation of subclinical vascular disease in psychosocial stress and dyslipidaemia." Thesis, Cardiff University, 2016. http://orca.cf.ac.uk/96729/.

Full text
Abstract:
Cardiovascular disease is a major cause of death and ill health across the world. Psychosocial factors are increasingly being recognised as potential cardiovascular risk factors, contributing to the development and progression of atherosclerotic disease. However, the pathways between psychosocial factors and cardiovascular disease are not yet fully understood. The aims of this thesis were to explore the associations between psychosocial factors (both chronic and acute stress) and measures of subclinical vascular disease, and to further develop and validate, a new method of assessing vasomotor
APA, Harvard, Vancouver, ISO, and other styles
7

Zhang, Qiuping. "Genetic variants of lipid transport genes, dyslipidaemia and coronary heart disease." Thesis, Queen Mary, University of London, 1997. http://qmro.qmul.ac.uk/xmlui/handle/123456789/1642.

Full text
Abstract:
Coronary heart disease (CHD) is one of the most common causes of death in Western Countries. Genetic factors playa major role in the aetiology of CHD, however, the primary defects responsible for the disease have not been identified in most cases. With the application of recombinant DNA technology, it is possible to analyse the putative aetiological role of candidate genes. The role of the Lipoprotein Lipase (LPL) gene and the Apolipoprotein AI-CIII-AIV gene cluster were examined in German and Chinese controls, dyslipidaemics and arteriopaths (coronary artery disease and/or peripheral artery d
APA, Harvard, Vancouver, ISO, and other styles
8

Tanyanyiwa, Donald Moshen. "Type 2 diabetes mellitus and dyslipidaemia: effects of genetic variation in African populations." Doctoral thesis, Faculty of Health Sciences, 2018. http://hdl.handle.net/11427/30132.

Full text
Abstract:
Background: Low-density lipoproteins (LDL) have been associated with damage to the cardiovascular system in patients with type 2 diabetes mellitus (T2DM). These patients are two (2X) to four (4X) times more likely to develop cardiovascular diseases (CVD) compared to non-diabetic patients due to dysfunctional lipoprotein metabolism. Normal lipid metabolism involves interconversion and transfer of molecules regulated by several enzymes such as Apolipoprotein E (ApoE) and proprotein convertase subtilisin/kexin type 9 (PCSK9). ApoE and PCSK9 are involved in clearance of lipoproteins and ther
APA, Harvard, Vancouver, ISO, and other styles
9

Nzeale, Jean Jacques Noubiap. "Prevalence of dyslipidaemia among adults in Africa: a systematic review and meta-analysis." Master's thesis, Faculty of Health Sciences, 2019. http://hdl.handle.net/11427/31183.

Full text
Abstract:
Background The burden of dyslipidaemia in Africa remains inadequately characterised. We aimed to estimate the prevalence of dyslipidaemia in African adults from hospital-based and community-based studies. Methods In this systematic review and meta-analysis, we searched MEDLINE via PubMed, EMBASE, African Journals Online, and African Index Medicus for studies published between Jan 1, 1980, and July 31, 2017, without language restriction. We assessed methodological quality of all crosssectional studies reporting on the prevalence of elevated concentrations of total cholesterol, LDL c
APA, Harvard, Vancouver, ISO, and other styles
10

ALIEVA, ASIIAT. "GENETIC DYSLIPIDAEMIAS IN THE ITALIAN AND RUSSIAN POPULATIONS:FROM THE CLINIC TO THE BENCH." Doctoral thesis, Università degli Studi di Milano, 2022. http://hdl.handle.net/2434/916008.

Full text
Abstract:
Genetic dyslipidemias are a heterogeneous group of disorders, and familial hypercholesterolemia (FH) is the most common one, that are characterized by abnormal levels of circulating lipoproteins and leading to premature cardiovascular diseases (CVD). Despite the need for an accurate and timely diagnosis due to high cardiovascular risk of those patients - there is still no well-managed system for a diagnosis and treatment of patients with severe dyslipidemias, - there are still some gaps between clinical and genetic diagnosis scores that need to be improved to increase their reliability at t
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Dyslipidaemic"

1

J, Betteridge D., ed. Dyslipidaemia. Baillière Tindall, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

(Gabriele), Riccardi G., ed. Clinician's manual on diabetic dyslipidaemia. Science Press, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

(Editor), P. Durrington, M. I. Mackness (Editor), J. P. Miller (Editor), and J.A.E. Rees (Editor), eds. The Year in Dyslipidaemia 2004 (Year in Dyslipidaemia). Informa Healthcare, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

The Year in Dyslipidaemia 2002 (Year in Dyslipidaemia). Informa Healthcare, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Reiner, Željko, Olov Wiklund, and John Betteridge. Lipids. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199656653.003.0015.

Full text
Abstract:
Dyslipidaemia, particularly elevated low-density lipoprotein (LDL) cholesterol, is one of the most important risk factors for cardiovascular disease (CVD). Low concentrations of high-density lipoprotein (HDL) cholesterol are independently associated with high CVD risk, while moderately elevated triglycerides are considered to be a marker of increased CVD risk. The presence of dyslipidaemias secondary to other conditions must be excluded before beginning treatment. All patients with familial hypercholesterolaemia are at high risk and should be treated by lipid-lowering therapy. Lifestyle change
APA, Harvard, Vancouver, ISO, and other styles
6

Thompson, Gilbert. Dyslipidaemia Clinical Practice. Taylor & Francis, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Morrell, Jonathan, and Gilbert Thompson. Dyslipidaemia in Clinical Practice. Taylor & Francis Group, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Thompson, Gilbert. Dyslipidaemia in Clinical Practice. Taylor & Francis Group, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Staff, Durrington P. Year in Dyslipidaemia 2002. Taylor & Francis Group, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Staff, Durrington P. Year in Dyslipidaemia 2003. Taylor & Francis Group, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Dyslipidaemic"

1

Rodriguez-Oquendo, Annabelle, and Peter O. Kwiterovich. "Dyslipidaemias." In Inborn Metabolic Diseases. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-15720-2_32.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Scobie, Ian N., and David Hopkins. "Diabetic dyslipidaemia." In Atlas of Diabetes Mellitus, 4th ed. CRC Press, 2023. http://dx.doi.org/10.1201/9781003342700-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Carlson, Lars A. "Diabetic dyslipidaemia." In Comprehensive lipid testing and management. Springer Healthcare Ltd., 2011. http://dx.doi.org/10.1007/978-1-908517-33-3_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lamarche, Benoît, and Jean-François Mauger. "Insulin Resistance and Dyslipidaemia." In Insulin Resistance. John Wiley & Sons, Ltd, 2005. http://dx.doi.org/10.1002/0470011327.ch14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kusters, D. M., Hans J. Avis, Maud N. Vissers, Barbara A. Hutten, John J. P. Kastelein, and Albert Wiegman. "Familial Dyslipidaemia in Children." In Guide to Paediatric Drug Development and Clinical Research. KARGER, 2010. http://dx.doi.org/10.1159/000315590.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ferro, Charles J. "Dyslipidaemia in Kidney Disease." In Management of Chronic Kidney Disease. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-42045-0_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Betteridge, D. John. "Management of Diabetic Dyslipidaemia." In Pharmacotherapy of Diabetes: New Developments. Springer US, 2007. http://dx.doi.org/10.1007/978-0-387-69737-6_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hamilton-Craig, Ian R., Karam Kostner, and Christian R. Hamilton-Craig. "Management of Dyslipidaemia in the Elderly." In Contemporary Cardiology. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-56514-5_25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ward, Natalie C., and Gerald F. Watts. "Emerging Therapies for Regulating Dyslipidaemias and Atherosclerosis." In Contemporary Cardiology. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-56514-5_33.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Lovic, Dragan, Manolis S. Kallistratos, and Athanasios J. Manolis. "Comorbidities Often Associated with Brain Damage in Hypertension: Dyslipidaemia." In Updates in Hypertension and Cardiovascular Protection. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-32074-8_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Dyslipidaemic"

1

L. ALSAADI, Yasmin. "SUBCLINICAL HYPOTHYROIDISM AND THEIR RELATION WITH DYSLIPIDEMIA IN IRAQI WOMEN." In VIII.International ScientificCongressofPure,AppliedandTechnological Sciences. Rimar Academy, 2023. http://dx.doi.org/10.47832/minarcongress8-10.

Full text
Abstract:
Subclinical hypothyroidism could be developed into serious health issues that affect the quality of life of the affected individuals.Thisstudyexamines the potential association between subclinical hypothyroidism and dyslipidemia. Subjects andMethods: Forty women were recruited in this study anddivided into two groups consisted of 20 women with subclinical hypothyroidism and 20 apparently healthy women designated as a control group. The participants’ age ranged between 20 to 42 years. Peripheral venous blood samples were collected,post 12hrs post fasting, for the measurement of serum thyroid pa
APA, Harvard, Vancouver, ISO, and other styles
2

Khan, Faheem, SINEAD WALSH, Robert Rutherford, and JJ J. GILMARTIN. "Association Between Dyslipidaemia And Polysomnography Variants To Investigate Sleep Apnoea." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a6083.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Offiah, G., C. O’Connor, C. Kennedy, et al. "14 The DA VINCI study: dyslipidaemia management in Ireland and Europe." In Irish Cardiac Society Annual Scientific Meeting & AGM (Virtual), October 7th – 9th 2021. BMJ Publishing Group Ltd and British Cardiovascular Society, 2021. http://dx.doi.org/10.1136/heartjnl-2021-ics.14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bracka, Irma, Elli Keramida, Eleni Bellou, et al. "Patterns of dyslipidaemia in postCOVID19 follow up patients; food for thought." In ERS International Congress 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/13993003.congress-2021.pa1170.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Díez, B. Cancela, C. Muñoz, R. Claramunt, S. Guijarro, MJ Barbero, and F. Horno. "5PSQ-026 Efficacy and safety of evolocumab in hypercholesterolaemia and mixed dyslipidaemia." In Abstract Book, 23rd EAHP Congress, 21st–23rd March 2018, Gothenburg, Sweden. British Medical Journal Publishing Group, 2018. http://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.380.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bikov, A., S. Bailly, U. Anttalainen, et al. "Insomnia is associated with dyslipidaemia in patients with OSA participating in ESADA." In Sleep and Breathing Conference 2025 abstracts. European Respiratory Society, 2025. https://doi.org/10.1183/23120541.sleepandbreathing-2025.89.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Mészáros, Martina, Ádám D. Tárnoki, Dávid L. Tárnoki, et al. "OSA, hypertension, diabetes and dyslipidaemia share common genetic background: Results of a twin study." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa881.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Monge, I., P. Acin, E. Navarrete-Rouco, et al. "4CPS-024 Efficacy, safety and acceptance of treatment with alirocumab or evolocumab in patients with dyslipidaemia." In 24th EAHP Congress, 27th–29th March 2019, Barcelona, Spain. British Medical Journal Publishing Group, 2019. http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.173.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Silva, L., G. Babaglioni, E. Festa, D. Paganotti, and TE Testa. "5PSQ-058 Efficacy evaluation of anti-PCSK9 drugs for the treatment of primary hypercholesterolaemia or mixed dyslipidaemia." In 28th EAHP Congress, Bordeaux, France, 20-21-22 March 2024. British Medical Journal Publishing Group, 2024. http://dx.doi.org/10.1136/ejhpharm-2024-eahp.392.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bikov, Andras, Sebastien Bailly, Gianfranco Parati, Carolina Lombardi, Ludger Grote, and Stefan Mihaicuta. "Periodic limb movements during sleep are associated with dyslipidaemia in patients with OSA. Results from the ESADA cohort." In ERS Sleep and Breathing 2023 abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/23120541.sleepandbreathing-2023.27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Dyslipidaemic' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography